Population impact of HPV vaccines: Summary of early evidence

Journal of Adolescent Health

Volumn 53, Issue 6, 2013, Pages 679-682

  Hariri, Susan ^a   Markowitz, Lauri E ^a   Dunne, Eileen F ^a   Unger, Elizabeth R ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Cervical cancer; HPV vaccine; Prevention

Indexed keywords

WART VIRUS VACCINE;

CONDYLOMA ACUMINATUM; FAMILY PLANNING; HETEROSEXUAL MALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MALE HOMOSEXUAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEXUAL HEALTH; UNITED STATES; UTERINE CERVIX CANCER; VERRUCA VULGARIS; WART VIRUS;

CERVICAL CANCER; HPV VACCINE; PREVENTION;

ADOLESCENT; ADULT; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; WORLD HEALTH;

EID: 84888061679     PISSN: 1054139X     EISSN: 18791972     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2013.09.018     Document Type: Article

References (24)

1. L.E. Markowitz, V. Tsu, and S.L. Deeks Human papillomavirus vaccine introduction-the first five years Vaccine 30 Suppl 5 2012 F139 F148
2. J. Dillner, S.K. Kjaer, and C.M. Wheeler Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial BMJ 341 2010 c3493
3. J. Paavonen, P. Naud, and J. Salmeron Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women Lancet 374 2009 301 314
4. L.E. Markowitz, S. Hariri, and E.R. Unger Post-licensure monitoring of HPV vaccine in the United States Vaccine 28 2010 4731 4737
5. S. Hariri, and L. Markowitz Monitoring HPV vaccine impact: Early results and ongoing challenges J Infect Dis 206 2012 1633 1635
6. D. Saslow, D. Solomon, and H.W. Lawson American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer Am J Clin Pathol 137 2012 516 542
7. L.E. Markowitz, S. Hariri, and C. Lin Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010 J Infect Dis 208 2013 385 393
8. T. Cummings, G.D. Zimet, and D. Brown Reduction of HPV infections through vaccination among at-risk urban adolescents Vaccine 30 2012 5496 5499
9. J.A. Kahn, D.R. Brown, and L. Ding Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction Pediatrics 130 2012 249 256
10. S.N. Tabrizi, J.M. Brotherton, and J.M. Kaldor Fall in human papillomavirus prevalence following a national vaccination program J Infect Dis 206 2012 1645 1651
11. C.K. Fairley, J.S. Hocking, and L.C. Gurrin Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women Sex Transm Infect 85 2009 499 502
12. B. Donovan, N. Franklin, and R. Guy Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: Analysis of national sentinel surveillance data Lancet Infect Dis 11 2011 39 44
13. H. Ali, B. Donovan, and H. Wand Genital warts in young Australians five years into national human papillomavirus vaccination programme: National surveillance data BMJ 346 2013 f2032
14. H. Ali, R.J. Guy, and H. Wand Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program BMC Infect Dis 13 2013 140
15. T.R. Read, J.S. Hocking, and M.Y. Chen The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme Sex Transm Infect 87 2011 544 547
16. M. Blomberg, S. Friis, and C. Munk Genital warts and risk of cancer: A Danish study of nearly 50 000 patients with genital warts J Infect Dis 205 2012 1544 1553
17. A. Leval, E. Herweijer, and L. Arnheim-Dahlstrom Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability J Infect Dis 206 2012 860 866
18. E.W. Flagg, R. Schwartz, and H. Weinstock Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: Potential impact of human papillomavirus vaccination Am J Pub Health 103 2013 1428 1435
19. H.M. Bauer, G. Wright, and J. Chow Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: An analysis of California public family planning administrative claims data, 2007-2010 Am J Pub Health 102 2012 833 835
20. R.T. Mikolajczyk, A.A. Kraut, and J. Horn Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany - an ecologic study Sex Transm Dis 40 2013 28 31
21. J. Oliphant, and N. Perkins Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services N Z Med J 124 2011 51 58
22. L. Baandrup, M. Blomberg, and C. Dehlendorff Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program Sex Transm Dis 40 2013 130 135
23. S.E. Powell, S. Hariri, and M. Steinau Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions Vaccine 3 2012 109 113
24. J.M. Brotherton, M. Fridman, and C.L. May Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: An ecological study Lancet 377 2011 2085 2092